IP Library Granted Patent US 9,067,071
Granted Patent B2
US 9,067,071 · App. 13/547,031 · Granted Jun 30, 2015

System and method for neuromodulation

Inventors: William E. Sanders (Chapel Hill, NC); Stephen C. Masson (Raleigh, NC); Terrance Ransbury (Chapel Hill, NC); Richard S. Stack (Chapel Hill, NC)
Assignee: Interventional Autonomics Corporation
A61N1/36114A61N1/36053A61N1/36135A61N1/0551A61N1/36139A61N1/056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,067,071
App. No.
13/547,031
Granted
Jun 30, 2015
Kind
B2
Abstract

A method of treating autonomic imbalance in a patient includes energizing a first therapeutic element disposed in a superior vena cava of the patient to deliver therapy to a parasympathetic nerve fiber (e.g. vagus nerve), and energizing a second therapeutic element disposed within the superior vena cava to deliver therapy to a sympathetic cardiac nerve fiber. A neuromodulation system includes a parasympathetic therapy element adapted for positioning within a blood vessel, a sympathetic therapy element adapted for positioning within the blood vessel; and a stimulator to energize the parasympathetic therapy element to deliver parasympathetic therapy to a parasympathetic nerve fiber disposed external to the blood vessel and energize the sympathetic therapy element within the blood vessel to deliver sympathetic therapy to a sympathetic nerve fiber disposed external to the blood vessel. The therapy decreases the patient's heart rate and elevates or maintains the blood pressure of the patient.

Claims (32)

1. A method of treating autonomic imbalance in a patient having a heart rate and a blood pressure, comprising:

delivering a neuromodulation therapy to sustain or increase the blood pressure while decreasing the heart rate, said neuromodulation therapy including

(a) stimulating at least one parasympathetic nerve fiber using a first therapeutic element comprising first electrodes disposed in a superior vena cava of the patient, wherein said stimulating comprises energizing at least one first electrode; and

(b) stimulating at least one sympathetic nerve fiber using a second therapeutic element comprising second electrodes disposed in the superior vena cava, the first electrodes and second electrodes being different electrodes, wherein staid stimulating comprises energizing at least one second electrode;

wherein steps (a) and (b) include positioning at least one first electrode and at least one second electrode against a posterior side of an internal wall of the superior vena cava.

2. The method of claim 1 , further including introducing a therapy device into the vasculature, the therapy device having the first and second therapeutic elements thereon, and advancing the therapy device within the vasculature to position the first and second therapeutic elements within the superior vena cava.

3. The method of claim 1 , wherein steps (a) and (b) are performed simultaneously.

4. The method of claim 1 wherein steps (a) and (b) are performed at separate times.

5. The method of claim 1 , further including positioning at least one first electrode against a postero-lateral wall of the superior vena cava and performing step (a) using said at least one first electrode.

6. The method of claim 1 , further including positioning at least one second electrode against a postero-medial segment of the superior vena cava and performing step (b) using said at least one second electrode.

7. The method of claim 1 , further including:

positioning at least one first electrode against a postero-lateral wall of the superior vena cava and performing step (a) using said at least one first electrode,

positioning at least one second electrode against a postero-medial segment of the superior vena cava and performing step (b) using said at least one second electrode.

8. The method of claim 7 , wherein said at least one first and second electrodes are positioned in contact with the wall of the SVC along a circumferential band extending 120° or less around the wall of the superior vena cava, the band having a mid-point at a posterior-most point around a circumference of the superior vena cava.

9. The method of claim 1 , wherein the at least one parasympathetic nerve fiber is a vagus nerve fiber.

10. The method of claim 1 , wherein the at least one sympathetic nerve fiber is a sympathetic cardiac nerve fiber.

11. The method of claim 1 , wherein the method includes positioning the first and second therapeutic elements in a segment of the superior vena cava extending between a right atrium and a junction of brachiocephalic veins.

12. The method of claim 1 , further including energizing the first and second therapeutic elements using a stimulator disposed external to the patient.

13. The method of claim 12 , further including monitoring blood pressure and heart rate of the patient, and modifying stimulus from the first and second therapeutic elements in response to detected changes in heart rate and/or blood pressure.

14. The method of claim 1 further including independently controlling stimulation of the sympathetic and parasympathetic nerve fibers.

15. A method of treating autonomic imbalance in a patient having a superior vena cava that includes a wall, comprising:

(a) positioning at least one first electrode within the superior vena cava against a postero-lateral segment of the wall of the superior vena cava, and stimulating at least one parasympathetic nerve fiber using said at least one first electrode; and

(b) positioning at least one second electrode within the superior vena cava against a postero-medial segment of the wall of the superior vena cava, and stimulating at least one sympathetic nerve fiber using said at least one second electrode.

16. The method of claim 15 , wherein the patient has a blood pressure and a heart rate, and wherein the method sustains or increases the blood pressure while decreasing the heart rate.

17. The method of claim 15 , wherein the at least one parasympathetic nerve fiber is a vagus nerve fiber.

18. The method of claim 15 , wherein the at least one sympathetic nerve fiber is a sympathetic cardiac nerve fiber.

19. The method of claim 15 , wherein step (a) includes energizing the first electrode and step (b) includes energizing the second electrode, wherein the first and second electrodes are different electrodes.

20. A method of treating autonomic imbalance in a patient having a heart rate and a blood pressure, comprising:

delivering a neuromodulation therapy to sustain or increase the blood pressure while decreasing the heart rate, said neuromodulation therapy including

(a) stimulating at least one parasympathetic nerve fiber using a first therapeutic element including a first electrode disposed in a superior vena cava of the patient; and

(b) stimulating at least one sympathetic nerve fiber using a second therapeutic element including a second electrode disposed in the superior vena cava,

wherein said at least one first and second electrodes are positioned in contact with the wall of the SVC along a circumferential band extending 270° or less around the wall of the superior vena cava, the band having a mid-point at a posterior- most point around a circumference of the superior vena cava.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: INTERVENTIONAL AUTONOMICS CORPORATION
To: NUXCEL2, LLC
Reel/Frame 058487/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2014
From: SYNECOR LLC
To: INTERVENTIONAL AUTONOMICS CORPORATION
Reel/Frame 033743/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2013
From: SANDERS, WILLIAM E; RANSBURY, TERRANCE; MASSON, STEPHEN C; STACK, RICHARD S
To: SYNECOR LLC
Reel/Frame 030461/0589 →
Continuity (7)
Provisional Application 61506164 · Jul 11, 2011
Provisional Application 61551418 · Oct 25, 2011
Provisional Application 61584812 · Jan 9, 2012
Provisional Application 61601501 · Feb 21, 2012
Provisional Application 61613433 · Mar 20, 2012
Provisional Application 61639982 · Apr 29, 2012
Related Publication 20130072997A1 · Mar 21, 2013